CUBEBIO’s cancer self-diagnostic device is capable of detecting 8 major cancer types (breast cancer, colorectal cancer, stomach cancer, liver cancer, lung cancer, pancreatic cancer, prostate cancer, and bladder cancer) at an early stage by using urine as a specimen.
As you start the device, you will be able to see ‘Test,’ ‘Instruction,’ ‘Administrator,’ ‘Illness History,’ ‘Summary,’ and ‘Setting’ on a screen. First, you put urine on a sensor. Next, you place it on a tray and insert it into an analyzer. Then, you press the ‘Test’ button with a light touch.
In about 15 minutes, you can do whatever you want, whether it be drinking a cup of coffee, taking a shower, or working, in a variety of settings, including home, hospital, pharmacy, coffee shop, office, convenience store, and bank. Finally, you check the diagnostic result on the screen, save it in your medical history, and monitor your health status on a frequent basis.
※ This video will be promoted worldwide in the first half of this year.
Introducing CUBEBIO and the company’s cancer self-diagnostic device
This brochure consists of 7 subjects:
1) Introducing CUBEBIO
2) Introducing CUBEBIO’s partners
3) Introducing ‘Cancer Early Detection and Self-Diagnosis’ program jointly developed by CUBEBIO and the Union for International Cancer Control
4) Introducing CUBEBIO’s cancer self-diagnostic device
5) Explaining how to use CUBEBIO’s cancer self-diagnostic device
6) Elaborating on CUBEBIO’s vision to create a new culture with its cancer self-diagnostic device
7) Showing a picture of the main parts of CUBEBIO’s cancer self-diagnostic device (an analyzer and a sensor)
CUBEBIO receives 'TI-3' rating for investment-type technology assessment, TCB (Technology Credit Bureau)
On February 28, 2020, CUBEBIO was recognized for its excellence in technology by acquiring the 'TI-3' rating of investment-type technology evaluation from NICE Information Service Co., Ltd. TCB (Technology Credit Bureau) is an evaluation of the economic value of technologies that can be generated through the technology commercialization, such as value, grade, or score. Based on the technology, NICE Information Service comprehensively analyzes and evaluates the technical ability, business feasibility, marketability, and management capabilities of the company. Technical evaluation for investment divides into 10 different grades from TI-1 to TI-10. (TI-1 being the best, TI-10 being the worst). TI-3, the third highest grade acquired by CUBEBIO, are awarded to companies with excellent technical skills that can be considered for the listing with a technical exception in Korea.
Close for 1day Close
Innovation in Cancer Diagnosis
The world’s first total solution cancer care companyRecent News
View More